Litcius/Paper detail

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Chongshu Jian, Jiajun Fu, Xu Cheng, Lijun Shen, Yan‐Xiao Ji, Xiaoming Wang, Shan L. Pan, Han Tian, Song Tian, Rufang Liao, Kehan Song, Haiping Wang, Xin Zhang, Yibin Wang, Zan Huang, Zhi‐Gang She, Xiao‐Jing Zhang, Lihua Zhu, Hongliang Li

2020Cell Metabolism35 citationsDOIOpen Access PDF

Topics & Concepts

SorafenibNonalcoholic steatohepatitisAMPKConfusionCancer researchMedicineHepatocellular carcinomaChemistryEndocrinologyInternal medicineNonalcoholic fatty liver diseaseFatty liverBiochemistryPsychologyEnzymeProtein kinase ADiseasePsychoanalysisLiver Disease Diagnosis and TreatmentCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated Receptors
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis | Litcius